UCMSCs as Treatment for Patients With Acute Ischemic Stroke (Stroke Neuroncell-EX)

Clinical trial NCT06129175 · RECRUITING

Trial details

NCT number: NCT06129175
Sponsor: Cytopeutics Sdn. Bhd.
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acute Ischemic Stroke

Start date: 2023-12-19
Primary completion: 2026-11-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.